SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Allergan Ligand (ALRI)
An SI Board Since August 1997
Posts SubjectMarks Bans Symbol
46 1 0 ALRI
Emcee:  Henry Niman Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
46 Henry, Will there be a great number of layoffs at ALRI associated w/ this mergesquetch-9/27/1997
45 Well, if LGND is covered big time on CNBC today, they shouldn't make the saHenry Niman-9/25/1997
44 Here's WSJ's interactive edition's version: Ligand and Allergan ExeHenry Niman-9/25/1997
43 Anyone who bought for more than $22 wasn't paying attention. Here's thHenry Niman-9/25/1997
42 I feel bad for those who bought above 22.squetch-9/24/1997
41 songw, Here's more good news for retinoids. The damage that smokers do to Henry Niman-9/17/1997
40 Stan, I just realized that this might help some readers understand the relationHenry Niman-9/17/1997
39 Stan, JNJ actually has a significant diabetes presence through its Lifescan subHenry Niman-9/10/1997
38 It seems you think WLA is better for diabetes, but a JNJ deal is better for lonsquetch-9/9/1997
37 ALRI can be called for $21.97. There are 3.25 million shares outstanding so itHenry Niman-9/9/1997
36 Henry, I think I am making this the remedial LGND thread. You say rumor is >squetch-9/9/1997
35 Thestreet just put out a Ligand story (their top story). They say that LLY is tHenry Niman-9/8/1997
34 stan, Last week buyers opened the price at 23 1/2 which is rediculous since ALRHenry Niman-9/5/1997
33 I feel bad if anybody buys above the call price. Good to see the coverage. I hosquetch-9/5/1997
32 songw,IBD didn't miss it. Check out today's IBD. Big (1/4 page) articlHenry Niman-9/5/1997
31 No we didn't miss it. Have been discussing little else on the LGND thread. Andrew H-9/3/1997
30 songw, See post #16: techstocks.comHenry Niman-9/3/1997
29 Did everyone miss ALRI 50% success rate of "complete and durable remissiosongw-9/3/1997
28 Henry, in the midst of the bashing you are taking on a couple of threads, I wanAndrew H-9/2/1997
27 Looks good Henry. I don't understand some of the more complex information, Larry-9/2/1997
26 LGND's "Retinoid Revolution" is a remarkable acheivement fromHenry Niman-9/2/1997
25 Just finished reading it there. Seems like good news.squetch-9/2/1997
24 Here's the front end of the LGND review I put up on Biotech Bash: I'll Henry Niman-9/2/1997
23 Stan, Check out Gold Standard Medical services. They give rundowns on new drugHenry Niman-9/1/1997
22 Here's what the WSJ had to say about retinoids when Vesanoid was approvHenry Niman-9/1/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):